Comments
Loading...

Ultragenyx Pharmaceutical

RARENASDAQ
Logo brought to you by Benzinga Data
$43.40
0.932.19%
At close: -
$43.40
0.000.00%
After Hours: 4:00 PM EDT

Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Quotes, Forecast and News Summary

Ultragenyx Pharmaceutical Stock (NASDAQ: RARE) stock price, news, charts, stock research, profile.

Open$42.70
Close$43.40
Volume / Avg.438.51K / 896.43K
Day Range$42.31 - $43.91
52 Wk Range37.02 - 60.37
Market Cap$4.01B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
54
Short Interest-
Days to Cover3.3

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RARE

FAQ

Q

How do I buy Ultragenyx Pharmaceutical (RARE) stock?

A

You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ultragenyx Pharmaceutical (RARE) competitors?

A

There are no as such competitors for Ultragenyx Pharmaceutical.

Q

What is the forecast, or price target, for Ultragenyx Pharmaceutical (RARE) stock?

A

Ultragenyx Pharmaceutical has a consensus price target of $94.13.

Q

What is the current price for Ultragenyx Pharmaceutical (RARE)?

A

The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $43.4 last updated January 30, 2025 at 4:00 PM EST.

Q

Does Ultragenyx Pharmaceutical (RARE) pay a dividend?

A

There are no upcoming dividends for Ultragenyx Pharmaceutical.

Q

When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?

A

Ultragenyx Pharmaceutical’s Q4 earnings are confirmed for Thursday, February 13, 2025.

Q

Is Ultragenyx Pharmaceutical (RARE) going to split?

A

There is no upcoming split for Ultragenyx Pharmaceutical.

Q

What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?

A

Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.